Recruiting OBSERVATIONAL NCT06597630
Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism，A Prospective Study
Sponsor: Qifu Li
Conditions
Primary Aldosteronism
Updated 1 time since 2024 Last updated: Sep 13, 2024 Started: Dec 1, 2023 Primary completion: Oct 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Primary Aldosteronism and is currently actively recruiting participants. Qifu Li leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Qifu Li
Data source: Chongqing Medical University
For direct contact, visit the study record on ClinicalTrials.gov .